A total of 590 consecutive episodes of nosocomial bacteremia were prospectively followed in 30 intensive care units (ICUs) over a 9-month period. The crude and directly related mortality rates were 41.6% and 19%, respectively. The predominant pathogens were coagulase-negative staphylococci (24.4%) and coagulase-positive staphylococci (17.5%). The most frequent sources of infection were intravenous catheters (37.1%). Multivariate analysis defined seven variables as independently influencing crude mortality: adult respiratory distress syndrome (ARDS), septic shock, multiorgan failure (MOF), mechanical ventilation, chronic hepatic failure, acute renal failure, and APACHE II score of 15 at diagnosis. Variables associated with a higher directly related mortality were septic shock, ARDS, acute renal failure, MOF, gram-negative or candidal bacteremia, source of bacteremia other than intravascular catheter, and severe sepsis. We conclude that preventing catheter colonization is crucial in reducing the incidence of bacteremia in an ICU, while improving outcome depends on better management of septic shock and associated complications.
Nosocomial infections occur in 5%-10% of patients admitted to hospitals in the United States [1] . The incidence of these infections in intensive care units (ICUs) is usually much higher than in other hospital departments [2] [3] [4] [5] [6] . Severity of underlying disease, invasive diagnostic and therapeutic procedures, contaminated life-support equipment, and the prevalence of resistant microorganisms are critical factors in the high rate of infection in ICUs [7] .
Nosocomial bloodstream infections carry a high fatality rate, and together with ventilator-associated pneumonia, they are the leading cause of deaths associated with nosocomial infections in ICUs. Critically ill patients run a higher risk of nosocomial bloodstream infection than do those admitted to other types of hospital wards. The incidence rate in two recent studies ranged between 2.67 and 6.72 episodes per 100 ICU admissions [8, 9] .
Despite important progress in antibiotic therapy and in ICU management of critically ill patients, the fatality rate of ICU patients who contract nosocomial bacteremia remains very high. The crude mortality associated with bloodstream infection often ranges from 35% to 60% [10, 11] , and the mortality directly attributable to the infection and not associated with underlying conditions is -25% [9, 12] .
Considerable effort has been devoted to studying the epidemiological factors and prognosis of both community-acquired and nosocomial bacteremia. However, despite the higher incidence of nosocomial bacteremia in ICUs, few studies have adequately analyzed such infection in this selected population.
The aim of this study was to carry out an epidemiological analysis of bloodstream infections acquired in 30 multidisciplinary ICUs in Spain and to determine by means of univariate and multivariate statistical techniques the influence of a number of clinical, microbiological and therapeutic variables on the outcome of a large series of critically ill patients with nosocomial bacteremia.
Patients and Methods

Patients
This prospective, multicenter study was carried out in 30 multidisciplinary ICUs in Spain. Of all adults admitted during the study period (April 1993 through December 1993) to the ICUs of participating hospitals, those for whom at least one blood culture was positive during the ICU stay were considered eligible. Participating institutions were primary and tertiary care hospitals with a large number of specialized units, including bone marrow, kidney, heart, and liver transplantation units.
Definitions
Terms used herein were defined as follows. A nosocomial bacteremic episode was considered to be the occurrence of any bacteremia beginning at least 72 hours after admission [13] and was defined by isolation of one or more organisms from the same patient on one or more occasions when clinical evidence suggested a common source. A new episode was considered when a new positive blood culture result was obtained >48 hours after the preceding positive blood culture result. Polymicrobial bacteremia was defined as isolation of more than one microorganism during a single bacteremic episode.
True bacteremia vs. contamination. Each positive blood culture was evaluated by the physicians directly in charge of the patient to determine whether it more probably represented true infection or contamination. This decision was based on multiple factors, including the patient's history, physical examination findings, body temperature, microbiological results of blood cultures, clinical course, results of cultures of specimens from other body sites, and percentage of positive blood cultures.
Source of bacteremia. On the basis of previously published criteria [8, 10] , the source of infection was designated as one of the following: lower respiratory tract, surgical wound, soft tissue, venous or arterial catheter-related, intraabdominal, urinary tract, other, or unknown. Secondary bacteremia was defined as that developing subsequent to a documented infection with the same microorganism at another body site, including episodes resulting from intravenous or arterial catheter infections.
Bacteremia of unknown origin was defined as bacteremia for which there was no documented distal source. Catheterrelated bacteremia was diagnosed when the same strain was isolated in blood cultures and in the semiquantitative culture of a catheter segment (yielding --15 colonies) or if there was a clear clinical response after withdrawal of the catheter (in cases in which the culture was not performed) and if no primary site other than the intravascular catheter could be identified.
The Acute Physiology and Chronic Health Evaluation (APACHE) II scoring system devised by Knaus et al. [14] was used to assess the severity of an acute illness. The definitions used previously by Knaus et al. [14] were also used to define the underlying diseases. A hematologic malignancy was considered to be present when results of the peripheral blood examination or the bone marrow or lymph node biopsy were consistent with this diagnosis. Nonhematologic malignancies were considered to be present only when a histologic diagnosis was available.
Patients were considered to have received corticosteroid therapy if they had taken 20 mg of prednisone daily (or an equivalent dosage) for at least 2 weeks or 30 mg of prednisone daily for at least 1 week before the positive blood culture result. Patients were considered to have received cytotoxic therapy if they had taken some kind of antineoplastic treatment for at least 4 weeks before the bacteremia episode. Organ transplantation patients were also considered immunocompromised. Patients were considered to have diabetes mellitus if they had required insulin therapy previously.
Risk factors during the ICU stay were defined as the following conditions: surgery, if it had taken place within 2 weeks prior to the episode; total parenteral nutrition, when the patient was receiving it at the time of a positive blood culture result; mechanical ventilation, if administered at the time the blood culture specimen was taken; leukopenia, if the total leukocyte count was <4,000/mm 3 ; granulocytopenia, if the absolute granulocyte count was <500/mm3 ; previous antibiotic therapy, if the patient had received antibiotics within the week prior to bacteremia; shock, when the patient had an episode in the week prior to the episode of bacteremia (defined on the basis of a systolic blood pressure of <90 mm Hg or a decrease of >30 mm Hg in a hypertensive patient, associated with signs of systemic hypoperfusion, which might include lactic acidosis, oliguria, or an acute alteration in mental status); and dialysis, when applied during the ICU stay.
Laboratory data recorded prospectively at the time the blood was drawn for culture included hemoglobin concentration, total leukocyte count, systolic blood pressure, temperature, and albumin level. We also recorded the APACHE II severity score at the time the blood culture specimen was drawn.
The systemic response to bacteremia was classified as sepsis, severe sepsis, or septic shock, as previously defined by Bone et al. [15] . Multiorgan failure (MOF) syndrome was considered when a patient had three or more organ system failures during at least a 24-hour period as a consequence of bacteremia. Disseminated intravascular coagulation (DIC) was considered when a platelet count of < 100,000/pt, reduction of fibrinogen concentration, high titers of fibrin-degradation products, and prolongations of the prothrombin time, thrombin time, and partial thromboplastin time were detected.
Adult respiratory distress syndrome (ARDS) due to bacteremia was defined as respiratory distress with presence of diffuse bilateral infiltrates, hypoxemia, poor pulmonary compliance, and pulmonary artery occlusion pressure of <18 mm Hg. Acute renal failure was defined by a serum creatinine concentration of >2 mg/dL or a 50% reduction in previous creatinine clearance. Acute liver failure was defined by an increase in bilirubin level of >3 mg/dL, prothrombin time of <60%, and a twofold increase in alanine aminotransferase level.
Septic metastasis was defined as the development of a septic complication, other than the source of infection, that was not present at the time bacteremia was detected. Endocarditis was documented on the basis of clinical, echocardiographic, or pathological evidence.
Antibiotic treatment. Therapy for the bacteremia was considered appropriate when at least one effective drug was included in the empirical and the definitive antibiotic treatments and when the dose and pattern of administration were in accordance with current medical standards. Empirical therapy was considered inappropriate when the microorganisms isolated in the bloodstream were not susceptible to the antimicrobial agents administered or if the patient was not receiving empirical antimicrobial agents before the blood culture result was known.
Outcome. Crude mortality included all deaths that occurred in the ICU among patients with nosocomial bacteremia. Mortality was considered to be related to the bacteremia if death ensued before any objective response to antimicrobial therapy was noted or if the bacteremia or some organ failure secondary to it (in patients with additional conditions) was considered a contributing factor to death. In-hospital mortality included all deaths that occurred in the hospital, during and after the ICU stay.
Statistical Analysis
Descriptive analysis was performed. Continuous variables are expressed as means (-± SD). Associations of categorical variables with mortality were assessed by means of the x2 test. Student's t-test was used for continuous variables [16] . Analysis of episodes and of patients was performed separately.
In the analysis of episodes, the associations between the source of infection and microorganisms were studied with respect to systemic response and related mortality. In the study of prognostic factors, the unit of analysis was the patient for crude mortality, and the first episode for related mortality. In the crude mortality analysis, for patients who had several episodes of bacteremia, a risk factor was considered positive if it was present during at least one of the episodes.
In the multivariate analysis, variables were selected for the logistic regression model if they were found in at least 10 of the patients and if they were significantly associated with mortality at a P value of <0.1. The stepwise logistic regression method was used for the estimation of coefficients and their standard errors. Odds ratios and 95% confidence intervals were calculated [17] .
Results
During the study period, a total of 16,216 patients were admitted to the participating ICUs. Four hundred and eightyone patients, with a mean (-± SD) APACHE II score of 16.2 ± 6.9 at admission and a mean (-± SD) age of 54.5 ± 17.3 years, had 590 episodes of true bacteremia, accounting for an infection rate of 3.6 episodes per 100 admissions. Fifty-seven additional episodes were considered contaminations.
A total of 409 patients had single episodes of bacteremia and 72 had multiple episodes (46 had 2 episodes, 17 had 3 episodes, 7 had 4 episodes, and 2 had 5 episodes). Two hundred of the 481 patients died in the ICU, representing a crude mortality of 41.6%. However, in only 112 of the 590 episodes (19%) was the death directly related to the bloodstream infection. The crude in-hospital mortality (mortality during all hospital stay) was 46.1%.
The mean interval (-± SD) between admission to the ICU and identification of nosocomial bacteremia was 15.9 ± 14.8 days (range, 3-136 days). For the patients who were hospitalized for >24 hours before ICU admission, a mean interval of 17.2 ± 15.6 days was spent in the ICU before the nosocomial bacteremia occurred, compared with 14.1 ± 13.5 days for patients admitted to the ICU from the community (P > .20). The mean total length of ICU stay for patients with bacteremia was 34.6 ± 29.5 days, whereas the mean total length of stay of all ICU patients admitted during the period of the study was only 6.1 days.
The systemic response to bacteremia was classified as sepsis in 371 episodes (62.8%), severe sepsis in 109 (18.5%), and septic shock in the remaining 110 (18.6%). The commonest sources of bacteremia (table 1) in the 590 episodes were intravascular catheter infections (37.1%), lower respiratory tract infections (17.5%), and intraabdominal infections (6.1%). The source of bacteremia could not be identified in 28.1% of the episodes.
The leading pathogens among cases of monomicrobial bacteremia (table 2) were gram-positive microorganisms (49.8%). Coagulase-negative staphylococci, Staphylococcus aureus, and Enterococcus species were the most frequently isolated gram-positive bacteria. Gram-negative microorganisms, in particular Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae, were identified in 32.6% of episodes. Fungemia due to Candida species represented only 4.4% of the episodes, and anaerobic flora was identified in only four episodes. Polymicrobial episodes were relatively common (12.7%). Cases of gram-negative bacteremia were associated with a higher incidence of septic shock and severe sepsis (P < .01) and higher related mortality (P < .01) than were gram-positive bacteremias (table 2) . Bacteremia-related mortality was higher in association with gram-negative infections than with grampositive infections, as determined on the basis of a range of risk factors during patients' stay in the ICU (table 3) . Mortality related to gram-negative bacteremia was also higher among cases of unknown origin, patients with ARDS and acute renal failure, and patients in whom sepsis was the systemic response.
The analysis of related mortality was performed only with regard to the first episodes of bacteremia in the 481 patients, and the variables associated with a significantly high related mortality are shown in table 4. Septic shock and severe sepsis, the presence of gram-negative or candidal organisms, source of bacteremia other than intravascular catheter, inappropriate treatment, and complications associated with bacteremia were all associated with a higher related mortality.
In contrast, when we analyzed the crude mortality, we analyzed 481 patients who had one or more episodes of bacteremia; the variables associated with a significantly higher crude mortality among patients who had nosocomial bacteremia in the ICU (table 5) were as follows: chronic hepatic failure (P < .01), mechanical ventilation (P < .01), dialysis (P < .01), granulocytopenia (P = .01), and previous shock (P < .01). A worse prognosis was also found for patients with severe sepsis, septic shock, MOF, DIC, ARDS, renal failure, hepatic failure, endocarditis, septic metastasis, inappropriate treatment, or an APACHE II score of > 15 when blood culture specimens were drawn.
The crude mortality was correlated to the severity of systemic response; it was as high as 80% among patients who had at least one episode of septic shock, compared with 26% among patients whose bacteremic episodes were manifested exclusively as sepsis (table 5) . Crude mortality rates were statistically different according to the source of the infection in the 409 patients who had only one episode of bacteremia. Bacteremias originating in the abdomen or respiratory tract were associated with the highest crude mortality (P = .04). Among 72 patients who had more than one episode of bacteremia the crude mortality was 36.1%, compared with a crude mortality of 42.5% among patients who had one episode of bacteremia (P value, NS).
By multivariate logistic regression (table 6), the variables that independently predicted the related mortality were MOF (P = .04), ARDS (P < .001), gram-negative or candidal bacteremia (P = --.02), severe sepsis (P = .12), septic shock (P < .001), acute renal failure (P < .01), and source of bacteremia other than intravascular catheter, (P = .02). Appropriateness of treatment was not chosen as a predictive variable by the multivariate analysis, but it was near statistical significance (P = .09).
When the dependent variable was crude mortality in the ICU, after adjustment for confounding, the following seven variables were identified as significantly influencing the prognosis for ICUacquired bacteremia: chronic hepatic failure (P = .04), mechanical ventilation at the time of diagnosis of bacteremia (P = .01), development of septic shock (P < .01), development of MOF (P = .03), development of ARDS (P < .01) or acute renal failure (P = .02), and an APACHE II score of at the time of diagnosis of bacteremia (P = .01).
Discussion
The incidence rate of nosocomial bacteremia in this multicenter study involving a large number of critically ill NOTE. ARDS = adult respiratory distress syndrome; DIC = disseminated intravascular coagulation; ICU = intensive care unit; MOF = multiorgan failure.
* P values correspond to the comparison of related mortality between gram-positive and gram-negative episodes of bacteremia.
patients was 3.6 episodes per 100 admissions. This incidence is similar to that noted in previous studies in small ICU populations [8, 9] and is higher than that in studies of nosocomial bacteremia in hospital wards [10] . Moreover, our results confirm that the intravascular catheter is the most frequent source of nosocomial bacteremia in ICU patients; this finding is in agreement with previous studies of the epidemiology of nosocomial infection in critically ill patients [8, 18] .
Coagulase-negative and -positive staphylococci were the most frequently isolated microorganisms in blood cultures in this study, followed by P. aeruginosa and A. baumannii. The high incidence of aerobic gram-positive cocci isolated (49.8%) corroborates the findings of recent studies of nosocomial infection in ICUs [8, 9] and seems to be related to the high incidence of bacteremia associated with intravascular catheters in critically ill patients and to the multiple antibiotic therapy used for gram-negative infections in ICU patients, which results in selection of gram-positive microorganisms.
Coagulase-negative staphylococci were the most prevalent cause of gram-positive bacteremia in our study, a finding confirming that they are the leading cause of ICU-acquired bacteremias. Because coagulase-negative staphylococci are often contaminants of blood cultures, we considered only episodes involving two or more positive blood cultures as significant cases of bacteremia due to coagulase-negative staphylococci. All isolations of coagulase-negative staphylococci from only a single blood culture were considered nonsignificant. Intravascular lines were the main sources of nosocomial bacteremia due to coagulase-negative staphylococci.
Gram-negative bacilli represented 32.6% of the microorganisms isolated, with respiratory and intraabdominal infections being the main sources. The present study found a high incidence of A. baumanii bacteremia, and this finding may be associated with the increasing importance of this microorganism in nosocomial infections in some ICUs. Indeed, a total of 42 episodes of A. baumanii bacteremia were diagnosed, and 80% of episodes occurred in three of the participating ICUs. These findings may be due in part to outbreaks of A. baumannii infections in these ICUs during the period of study, a phenomenon described in previous studies [19, 20] .
This study is unique in evaluating the systemic response to bacteremia in critically ill patients according to the definitions of NOTE. ARDS = adult respiratory distress syndrome; COPD = chronic obstructive pulmonary disease; DIC = disseminated intravascular coagulation; ICU = intensive care unit; MOF = multiorgan failure. sepsis, severe sepsis, and septic shock recently proposed by the American College of Chest Physicians and the Society of Critical Care Medicine Consensus Conference [15] . In accordance with these definitions, 62.8% of the episodes of nosocomial bacteremia in this study were manifested as sepsis, 18.5% as severe sepsis, and 18.6% as septic shock. The incidence of septic shock was lower than in previous studies that estimated that shock developed in about 40% of patients with sepsis [21, 22] . However, these differences may be related to variations in the definitions of sepsis and its sequelae, because the group classified as severe sepsis in our study may have included episodes of bacteremia that were previously classified as septic shock.
The degree of severity of the systemic manifestations of infection also correlated with a high bacteremia-related mortality. Indeed, for episodes of bacteremia associated with intravascular catheters, the related mortality was 10%, while only 12.8% of these episodes presented as septic shock; on the other hand, the related mortality was >20% when the source of bacteremia was the lower respiratory tract, abdomen, or urinary tract, all of which caused a higher incidence of episodes classified as severe sepsis and septic shock.
Although in previous studies the microbial variables were less important than host conditions and therapy, when we analyzed the systemic response associated with the different pathogens isolated, the incidence of septic shock caused by grampositive microorganisms was 13.6% (with a related mortality of 11.6%), whereas the incidence of septic shock in bacteremias caused by gram-negative microorganisms was 23% (and related mortality, 26.2%) (P < .01). In a previous study analyzing the risk factors for septic shock, Aube et al. [23] also found a difference in the incidence of septic shock involving gramnegative and gram-positive microorganisms (29% vs. 19%).
Moreover, high case-fatality rates have been observed in patients with sepsis due to P. aeruginosa or Acinetobacter species [23] [24] [25] , and in our study these microorganisms were the most important cause of gram-negative bacteremia; this would also explain in part the differences found between grampositive and gram-negative bacteremias in our study. The difference in systemic response and related mortality between gram-positive and gram-negative microorganisms in the present study was probably also associated with the different sources of bacteremia. NOTE. ARDS = adult respiratory distress syndrome; COPD = chronic obstructive pulmonary disease; DIC = disseminated intravascular coagulation; ICU = intensive care unit; MOF = multiorgan failure.
Indeed, the most frequent source of gram-positive bacteremia was the intravascular catheter, which caused the lowest percentage of related mortality and septic shock. In contrast, only 24% of episodes of gram-negative bacteremia originated in intravascular catheters, and these episodes had a lower mortality than other sources of gram-negative bacteremia, similar to that of gram-positive catheter-related bacteremias (12.5% vs. 10%).
For this reason, the differences in related mortality and systemic response noted above seem to be due to the higher incidence of gram-positive than gram-negative bacteremias associated with intravascular catheters (140 episodes vs. 40 episodes). Indeed, in the multivariate analysis with related mortality as the dependent variable, both gram-negative bacteremias and fungemias and noncatheter origin of bacteremia were independently associated with higher mortality.
These results suggest that gram-negative bacteremias are associated (1) with higher related mortality because of their special characteristics and the higher virulence of these microorganisms, (2) with a higher incidence of severe sepsis and septic shock, and (3) with a higher incidence of bacteremias originating from sources other than a catheter.
The mean interval between ICU admission and development of bacteremia was 15.9 ± 14.8 days. Our results are similar to those of the study by Rimailho et al. [26] , who analyzed enterococcal bacteremia in critically ill patients and found a mean ICU stay of 15 days prior to onset of bacteremia. However, our results differ from those of a recent study of bacteremia in critically ill patients by Pittet et al. [9] , who found a median length of previous stay in the ICU of 6 days. These authors also analyzed the excess length of stay of the critically ill patients who had nosocomial bacteremia. They found an average stay of 22 days in ICU bacteremia cases vs. 13.6 days for controls.
In our study there was no matched control group to compare with, but the mean length of total ICU stay for patients with bacteremia was 34.6 days, whereas the mean total length stay of all ICU patients admitted during the period of study was only 6.1 days. These results agree with those of other studies and suggest that nosocomial bloodstream infections result in a prolongation of the hospital stay [27, 28] .
The crude mortality among 481 patients with one or more bacteremic episodes in this study was 41.6%. However, when we analyzed the episodes of bacteremia and the mortality di- rectly associated with the episodes, we found a mortality of 19%. These results agree with those of previous studies of bacteremia in ICUs. Indeed, Rello et al. [8] reported a crude mortality of 31% and a 20% mortality directly related to the infection, while Pittet et al. [9] , who performed a pairwisematched case-control study, reported a crude mortality of 50% among cases and an attributable mortality of 35%. These results also agree with those of a study by Weinstein et al. [11] , who reported a total mortality of 42% in 500 episodes of nosocomial and community-acquired bacteremia; however, only half of the deaths were directly attributable to infection, a finding confirming that underlying conditions are responsible in part for the high mortality associated with bacteremia.
In our population polymicrobial bacteremia was associated with a trend toward higher mortality (46%), but the difference with respect to monomicrobial bacteremia was not statistically significant. These results agree with those of some previous studies of polymicrobial bacteremia that showed a mortality of >30% [29, 30] . In contrast, Rello et al. [31] reported a lower rate of mortality (7.1%) for critically ill patients with polymicrobial bacteremia. They attributed this finding to the fact that the main source of bacteremia was intravascular catheters (54.5% of polymicrobial episodes). In our study, only 38% of polymicrobial bacteremias originated in intravascular devices; the intraabdominal and lower respiratory tract were the main sources.
Because crude mortality cannot differentiate between mortality directly related to bacteremia and mortality attributable to underlying conditions, we were aware that different factors may influence the prognosis if we considered directly related mortality or crude mortality. For this reason we performed a double multivariate analysis with different variable dependents: one, related mortality, and the other, crude mortality. In the related mortality analysis, in addition to level of systemic response and associated complications, we found that the type of microorganisms involved and the source of bacteremia played an important role in the prognosis.
In the crude mortality analysis, we found that in addition to systemic response and associated complications, mechanical ventilation at the time of development of bacteremia, chronic hepatic failure, and an APACHE II index score of at the time of diagnosis of bacteremia were chosen as factors by the statistical model; this seems to indicate that underlying diseases and the severity of patients' conditions markedly influence crude mortality among ICU patients with nosocomial bacteremia.
This was an observational study, and some possible limitations related to the uniformity of antimicrobial therapy and hemodynamic management of systemic response to bacteremia should be noted. However, as the study involved a large number of ICUs, the results avoid the problem of potential bias associated with the selection of a specific population and may be applied to other hospitals.
In summary, this multicenter study involving a large number of patients admitted to ICUs (> 16,000 patients) confirms the increase in gram-positive bacteremia in critically ill patients and identified intravascular catheters and lower respiratory tract infection as the main sources of bacteremia in these patients. These results suggest that improving the prevention of catheter infection and nosocomial pneumonia should be a primary objective in attempts to reduce the incidence of bacteremia in the ICU.
Furthermore, this study shows that the immediate prognosis after an episode of nosocomial bacteremia (related mortality) correlated with the grade of systemic response, the type of microorganism involved and the different sources of bacteremia. In contrast, survival after bacteremia but subsequent death in the ICU (crude mortality) was associated with in addition to systemic response the severity of the patient's condition at the time of bacteremia (APACHE II score) and underlying conditions.
In any case, the management of septic shock and associated complications, such as ARDS or MOF, and the appropriateness of antibiotic treatment are the most important modifiable variables affecting the outcome for patients with nosocomial bacteremia in the ICU.
